Target
Glucose-dependent insulinotropic receptor
Ligand
BDBM50523012
Substrate
n/a
Meas. Tech.
ChEMBL_1888841 (CHEMBL4390518)
EC50
69±n/a nM
Citation
 Harada, KMizukami, JWatanabe, TMori, GUbukata, MSuwa, KFukuda, SNegoro, TSato, MInaba, T Optimization of oxadiazole derivatives with a spirocyclic cyclohexane structure as novel GPR119 agonists. Bioorg Med Chem Lett 29:2100-2106 (2019) [PubMed]  Article 
Target
Name:
Glucose-dependent insulinotropic receptor
Synonyms:
G-protein coupled receptor 119 (GPR119) | GP119_HUMAN | GPR119 | Glucose-dependent insulinotropic receptor
Type:
Protein
Mol. Mass.:
36901.49
Organism:
Homo sapiens (Human)
Description:
Q8TDV5
Residue:
335
Sequence:
MESSFSFGVILAVLASLIIATNTLVAVAVLLLIHKNDGVSLCFTLNLAVADTLIGVAISGLLTDQLSSPSRPTQKTLCSLRMAFVTSSAAASVLTVMLITFDRYLAIKQPFRYLKIMSGFVAGACIAGLWLVSYLIGFLPLGIPMFQQTAYKGQCSFFAVFHPHFVLTLSCVGFFPAMLLFVFFYCDMLKIASMHSQQIRKMEHAGAMAGGYRSPRTPSDFKALRTVSVLIGSFALSWTPFLITGIVQVACQECHLYLVLERYLWLLGVGNSLLNPLIYAYWQKEVRLQLYHMALGVKKVLTSFLLFLSARNCGPERPRESSCHIVTISSSEFDG
  
Inhibitor
Name:
BDBM50523012
Synonyms:
CHEMBL4476507
Type:
Small organic molecule
Emp. Form.:
C25H34FN3O4
Mol. Mass.:
459.5536
SMILES:
CC(O[C@H]1CC[C@@]2(COC(C)(C)C2)CC1)c1nc(no1)-c1ccc(CC(=O)N(C)C)c(F)c1 |r,wU:6.6,3.2,(19.89,-19.94,;19.91,-21.49,;21.32,-22.11,;22.57,-21.21,;22.41,-19.68,;23.66,-18.77,;25.08,-19.41,;25,-17.87,;26.44,-17.31,;27.4,-18.5,;28.73,-17.72,;28.74,-19.26,;26.57,-19.8,;25.23,-20.94,;23.98,-21.84,;18.67,-22.39,;17.2,-21.91,;16.29,-23.16,;17.2,-24.41,;18.67,-23.93,;14.75,-23.16,;13.98,-21.83,;12.44,-21.83,;11.67,-23.17,;10.14,-23.17,;9.36,-21.84,;10.13,-20.51,;7.83,-21.85,;7.06,-20.52,;7.07,-23.18,;12.44,-24.49,;11.67,-25.83,;13.98,-24.49,)|
Structure:
Search PDB for entries with ligand similarity: